These 10 Stocks are Falling Today

Published on September 14, 2022 at 3:01 pm by Fahad Ali Khan in News

In this article, we will take a look at the 10 stocks that are falling today. If you want to check out some other companies losing value on Wednesday, go directly to These 5 Stocks are Falling Today.

All three major U.S. indices marginally moved up on Wednesday morning, a day after plummeting sharply on the consumer price index (CPI) report. Tuesday’s drop was primarily attributed to CPI data that showed inflation ticked up 0.1 percent in August.

The latest surge in CPI fueled investors’ concerns about a further hike in interest rates by the Federal Reserve that could negatively affect the stocks. Meanwhile, economics experts are divided on where the stock market is heading. Some expect inflation to cool down and drive the markets, while others anticipate a new dip.

Now, let’s have a look at the notable losers of this morning. Railroad stocks, including Union Pacific Corporation (NYSE:UNP) and CSX Corporation (NASDAQ:CSX), moved down ahead of a potential strike from workers. The railroad worker unions are seeking a new contract and have threatened to strike if an agreement is not reached by the end of this week.

In addition, Block, Inc. (NYSE:SQ), Altimmune, Inc. (NASDAQ:ALT) and Nucor Corporation (NYSE:NUE), were also among the top losers on Wednesday. We will discuss the reasons behind the downward movement of these stocks in the remaining article.

Photo by Adam Nowakowski on Unsplash

10. Innovid Corp. (NYSE:CTV)

Number of Hedge Fund Holders: 8

Shares of Innovid Corp. (NYSE:CTV) lost more than 12 percent of their value on Wednesday morning after Morgan Stanley issued an “Underweight” rating for the independent advertising platform.

Morgan Stanley analyst Brian Nowak thinks the company’s growth opportunities are already mirrored in its stock price. He set a price target of $2.70 per share for Innovid Corp. (NYSE:CTV). Moving forward, Nowak also expects negative sales revisions amid a potential deterioration in the macro environment.

Innovid Corp. (NYSE:CTV) shares have struggled to advance this year. The stock has lost nearly 57 percent of its value so far in 2022.

9. Vintage Wine Estates, Inc. (NASDAQ:VWE)

Number of Hedge Fund Holders: 10

Shares of Vintage Wine Estates, Inc. (NASDAQ:VWE) plunged nearly 40 percent this morning after issuing a weak sales outlook for its fiscal year 2023. The producer of alcoholic beverages expects to generate revenue in the range of $300 – $310 million, below the consensus of $330.37 million.

Vintage Wine Estates, Inc. (NASDAQ:VWE) received a downgrade from Canaccord following its gloomy guidance. The research firm lowered its ratings for the Nevada-based company from “Buy” to “Hold” and cut its price target from $15 to $5.50.

The company issued the forecast along with its fiscal fourth-quarter results. Vintage Wine Estates, Inc. (NASDAQ:VWE) earned 17 cents per share on an adjusted basis, topping estimates of 14 cents.

Revenue for the quarter climbed 32 percent versus last year to $75.54 million, ahead of the expectations of $74.24 million. Vintage Wine Estates, Inc. (NASDAQ:VWE) also released its segment-wise sales results. Its direct-to-consumer revenue jumped 29 percent to $23.1 million, B2B revenue climbed 55 percent to $30.6 million and wholesale revenue rose 23 percent to $21.6 million in the quarter.

Like Vintage Wine Estates, Inc. (NASDAQ:VWE), shares of Union Pacific Corporation (NYSE:UNP), CSX Corporation (NASDAQ:CSX) and Block, Inc. (NYSE:SQ) also fell this morning.

8. POINT Biopharma Global Inc. (NASDAQ:PNT)

Number of Hedge Fund Holders: 13

Shares of POINT Biopharma Global Inc. (NASDAQ:PNT) dived over 10 percent after the opening bell today. The drop came after the clinical-stage pharmaceutical firm announced an underwritten public offering of 13.9 million shares of its common stock.

POINT Biopharma Global Inc. (NASDAQ:PNT) plans to offer the stock at $9 apiece. It has also given underwriters a one-month option to acquire an additional 2.085 million shares. The company has hired Piper Sandler and Guggenheim Securities as mutual book runners for the offering.

The company expects to generate about $125 million from the sale, excluding commissions and other related costs. POINT Biopharma Global Inc. (NASDAQ:PNT) plans to use the capital primarily to fund its clinical research and other development programs.

7. Flowserve Corporation (NYSE:FLS)

Number of Hedge Fund Holders: 13

Shares of Flowserve Corporation (NYSE:FLS) slipped over two percent this morning after releasing an update related to its third quarter. The company said it employed a new enterprise resource planning system in certain manufacturing and response centers across North America at the start of Q3.

Flowserve Corporation (NYSE:FLS) added that it faced challenges while implementing the new system. Those challenges negatively affected its volumes during the quarter. Moreover, the company also cautioned about an unexpected surge in corporate costs. Flowserve Corporation (NYSE:FLS) expects these factors to drag its Q3 adjusted earnings by 18 – 22 cents per share.

On the bright side, Flowserve Corporation (NYSE:FLS) said it enjoyed solid bookings momentum in the third quarter. The company projected bookings of over $1 billion for Q3.

6. Li-Cycle Holdings Corp. (NYSE:LICY)

Number of Hedge Fund Holders: 15

Shares of Li-Cycle Holdings Corp. (NYSE:LICY) turned red in pre-market trading Wednesday after the lithium-ion batteries recycler posted lower-than-expected results for its fiscal third quarter.

Li-Cycle Holdings Corp. (NYSE:LICY) reported an adjusted loss of 16 cents per share, wider than analysts’ average estimate for a loss of 12 cents. Revenue came in at $1.97 million, missing the expectations of $10.63 million.

Looking forward, Li-Cycle Holdings Corp. (NYSE:LICY) now expects black mass production in the range of 3,500 – 3,800 tonnes for its fiscal year 2022.

Speaking on the results, CEO Ajay Kochhar said in a statement:

“We continue to see robust battery supply from our global customers and are making strides in strategically advancing our Spoke & Hub network to align with their growing needs. The recent enactment of the Inflation Reduction Act in the U.S. is yet another meaningful tailwind for our Spoke & Hub business model.”

Click to continue reading and see These 5 Stocks are Falling Today.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Published on November 14, 2025 at by Inan Dogan, PhD

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

175 Teslas
107 Amazons
140 Metas
84 Googles
65 Microsofts
And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s why this is a deal you can’t afford to pass up:

• Access to our Detailed Report on this Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.

• 11 New Issues of Our Premium Readership Newsletter: You will also receive 11 new issues and at least one new stock pick per month from our monthly newsletter’s portfolio over the next 12 months. These stocks are handpicked by our research director, Dr. Inan Dogan.

• One free upcoming issue of our 70+ page Quarterly Newsletter: A value of $149

• Bonus Reports: Premium access to members-only fund manager video interviews

• Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.

• 30-Day Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund within 30 days, no questions asked.

If you’re thinking about getting in, don’t wait – because once Wall Street catches wind of this story, the easy money will be gone.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $9.99 a month.

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up